Cryptic telomere deletions have been proposed to be a significant cause ofidiopathic mental retardation. We present two unrelated subjects, with normal G banding analysis, in whom 22q telomere deletions were serendipitously detected at two different institutions using fluorescence in situ hybridisation (FISH). Both probands presented with several of the previously described features associated with 22q deletions, including hypotonia, developmental delay, and absence of speech. Our two cases increase the total number of reported 22q telomere deletions to 19, the majority of which were identified by cytogenetic banding analysis. With the limited sensitivity of routine cytogenetic studies (-2-5 Mb), these two new cases suggest that the actual prevalence of 22q telomere deletions may be higher than currentiy documented. Of additional interest is the phenotypic overlap with Angelman syndrome (AS) as it raises the possibility of a 22q deletion in patients in whom AS has been ruled out. The use oftelomeric probes as diagnostic reagents would be useful in determining an accurate prevalence of chromosome 22q deletions and could result in a significantiy higher detection rate of subtelomeric rearrangements.
scribed features associated with 22q deletions, including hypotonia, developmental delay, and absence of speech. Our two cases increase the total number of reported 22q telomere deletions to 19, the majority of which were identified by cytogenetic banding analysis. With the limited sensitivity of routine cytogenetic studies (-2-5 Mb), these two new cases suggest that the actual prevalence of 22q telomere deletions may be higher than currentiy documented. Of additional interest is the phenotypic overlap with Angelman syndrome (AS) as it raises the possibility of a 22q deletion in patients in whom AS has been ruled out. The use oftelomeric probes as diagnostic reagents would be useful in determining an accurate prevalence of chromosome 22q deletions and could result in a significantiy higher detection rate of subtelomeric rearrangements. Since the initial description of a potential partial monosomy 22q syndrome in 1985 by Watt et al,l a total of 17 cases of monosomy 22q13.3 have been reported. Two of the deletions were the product of gross cytogenetic rearrangements,' 2 1l were cytogenetically apparent terminal deletions," and two additional cases were more subtle "suspected" deletions, later confirmed by FISH.9 Two submicroscopic deletions were detected by Southern blot analysis in a screening of a population of mentally retarded subjects.'0
The patients reported to have 22q13 deletions share several clinical features. Many of the patients presented with developmental delay, particularly of motor milestones. In addition, most were hypotonic. Interestingly, in all reported cases, expressive language was either absent, severely delayed, or unascertainable owing to the age of the patient. Traits which were less frequently described but have been seen in several patients include epicanthic folds, dysplastic ears, and dolichocephaly.7 9 We describe two additional 22q telomere deletions which were unexpectedly detected by FISH after routine cytogenetics failed to discover any visible abnormalities. While both patients have phenotypic similarities to previously described 22q deletion patients, they were referred for cytogenetic analysis and FISH studies to rule out DiGeorge and Angelman syndromes, respectively. This is the first report of serendipitously detected 22q13.3 deletions following normal cytogenetics results.
Subjects and methods

CASE REPORTS
Case 1, aged 5, is the second child of healthy, non-consanguineous parents. Her older brother is not reported to have any medical problems. The pregnancy was complicated by gestational diabetes, and she was delivered at term by caesarean section because of fetal distress, weighing 2580 g. She required nasogastric feeding for three days postnatally and was subsequently discharged at 5 days of age. Hypotonia and developmental delay were noted in infancy. She did not start walking until -18 months and her gait remained unsteady with frequent falls. Her parents also noted a high pain tolerance. The family history included two matemal uncles with dyslexia and one with visual-spatial perception problems.
At 18 months, case 1 was assessed by a neurologist and investigations, including cranial MRI and CT scans as well as brainstem auditory evoked responses (BAERs), were normal. She never had seizures and an EEG at the age of 3 was normal. By the age of 41/2, her persistent generalised developmental delay, particularly in the area of expressive speech, and her unsteady gait raised the possible diagnosis of Angelman syndrome. She was referred for cytogenetic and molecular genetic evaluation.
On examination at 4 years 10 months, her weight (17.8 kg), height (112 cm), and head circumference (50.5 cm) were all on the 50th centile. She had marked hypotonia, lax joints, and an uncoordinated gait. Her facial features were not dysmorphic. Her fingers were relatively wide with broad tips and she had bilateral fifth finger clinodactyly; there was mild 2-3 syndactyly of her toes. Physical examination was otherwise unremarkable. Psychological assessment at the time (Mullen Scales of Early Learning) placed her verbal and non-verbal skills at the 8 to 9 month and the 16 to 17 month level, respectively. The Bayley Scales of Infant Development indicated a mental age equivalent of 11-12 months. Case 2, aged 5, is the second child of non-consanguineous parents. He was born at term, after an uncomplicated pregnancy, weighing 3742 g (90th centile). Although his neonatal period was unremarkable, developmental delay was noted in infancy. He sat unassisted at about 9-10 months and walked at 22 months. BAERs were borderline and a cranial MRI scan at the age of 2½/2 showed diminished periventricular white matter. Family history included a maternal great aunt with mental retardation and a maternal uncle with learning disabilities.
By the age of 5, case 2 had no speech, but was able to use a few signs. On physical exam- ination his height was 107 cm (25th centile), his weight was 40.5 kg (50th centile), and his head circumference was 52.5 cm (75th centile). His muscle tone was generally decreased and he made poor eye contact. He had bilateral epicanthic folds, narrow palpebral fissures, and a broad nasal root.
Previous investigations, which were all normal, included peripheral blood cytogenetic studies, molecular studies for fragile X, serum and urine amino acids, thyroid function tests, and an ophthalmological examination. He had narrow palpebral fissures, a broad nasal root, and his facial features were somewhat reminiscent of velocardiofacial syndrome. He was referred for further FISH evaluation to rule out a deletion at 22ql 1.2.
CYTOGENETICS AND FISH
Routine cytogenetic analysis at a greater than 550 band level was performed on peripheral blood samples from both piobands and the parents of case 2 at either the University of Chicago Genetic Services (Chicago, IL) or Kaiser Permanente (Oakland, CA) using standard procedures.
Chromosome preparations from peripheral blood were used for fluorescence in situ hybridisation (FISH) analysis. FISH was initially performed on case 1 using D15S10, a probe for the Prader-Willi/Angelman region on chromosome 15 (Oncor Inc, Gaithersburg, MD). Samples from both patients were hybridised with a digoxigenin labelled commercial DiGeorge chromosome region probe, D22S75, containing the telomeric control locus D22S39, according to the manufacturer's conditions (Oncor Inc). The rapid wash procedure was followed with no amplification. The two probands were further studied with a chromosome 22q unique telomere probe, ICRFc106G1220, labelled with digoxigenin-11 -dUTP." A chromosome 14/22 alpha satellite probe, labelled with biotin-1 6-dUTP, was used to identify chromosome 22. Probe preparation, hybridisation, analysis, and imaging were carried out using previously described methods. 2 Parental chromosome FISH studies were performed with the commercial DiGeorge probe and cosmid 106G1220 to rule out an inherited event.
MICROSATELLITE ANALYSIS
Microsatellite analysis was performed as previously described'3 to confirm FISH results and determine the parental origin of deletion. Whole cell lysates were made from 200 ,ul of peripheral blood using the Qiamp blood lysis kit (Qiagen Inc, Chatsworth, CA). One gl of a 1:5 dilution of the cell lysate was used per PCR assay. Five Genethon STR markers from the distal portion of 22q were used: D22S282, S 1179, S 1140, S928, and S 1169 (markers are listed in order from centromere to telomere).
Results
CASE 1
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The de novo deletion in both of our probands was determined to be of paternal origin. Two previously reported cases6 10 were also paternal deletions. However, in four further ine cytogenetic and cases,' 7 9 10 a maternal origin of the deletion CFS deletion. Rou-was reported. Therefore, imprinting is an led to identify any unlikely mechanism associated with the phenobroximal 22q VCFS type in these deletions.
nt on both homo-
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Discussion
Terminal 22q deletion patients share a common phenotype including hypotonia, developmental delay, and absence of speech. The
